HomeTagsMolDX Program

MolDX Program

Healthcare

Epic Sciences Announces Medicare Coverage for Breast-Cancer Focused ctDNA Gene Panel

Business Wire - April 20, 2023

Epic Sciences, Inc. announced that the company’s 56-gene ctDNA panel for genomic profiling of metastatic breast cancer is covered by the MolDX program (administered...

Healthcare

Lucid Diagnostics Provides Update on Newly Published Future Effective Medicare Local Coverage Determination on Molecular Testing for Detection of Esophageal Precancer and Cancer

PR Newswire - April 4, 2023

Lucid Diagnostics Inc, a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed In , announced that, the MolDX Program published a Future Effective...